Skip to main content
Have a personal or library account? Click to login
Prevalence and Determinants of Endothelial Dysfunction among Adults Living with HIV in Northwest Nigeria Cover

Prevalence and Determinants of Endothelial Dysfunction among Adults Living with HIV in Northwest Nigeria

Open Access
|Oct 2023

References

  1. Waheed U, Azmat M, Arshad M, Ar-shad A, Zaheer H. HIV AIDS Epidemic and Global Health. HIV/AIDS Research and Treatment—Open Journal. 2016; 2(4): 105107. DOI: 10.17140/HARTOJ-2-118
  2. Vachiat A, Dix-Peek T, Duarte R, Manga P. Endothelial dysfunction in HIV-positive patients with acute coronary syndromes. Cardiovascular Journal of Africa. 2020; 31(2): 5864. DOI: 10.5830/CVJA-2019-040
  3. Marincowitz C, Genis A, Goswami N, De Boever P, Nawrot TS, Strijdom H. Vascular endothelial dysfunction in the wake of HIV and ART. FEBS Journal. 2019; 286(7): 12561270. DOI: 10.1111/febs.14657
  4. Stein JH, Klein MA, Bellehumeur JL, McBride PE, Wiebe DA, Otvos JD, et al. Use of human immunodeficiency virus-1 protease inhibitors is associated with atherogenic lipoprotein changes and endothelial dysfunction. Circulation. 2001; 104(3): 257262. DOI: 10.1161/01.CIR.104.3.257
  5. Pirro M, Mannarino MR, Francisci D, Schiaroli E, Bianconi V, Bagaglia F, et al. Urinary albumin-to-creatinine ratio is associated with endothelial dysfunction in HIV-infected patients receiving antiretroviral therapy. Scientific Reports. 2016; 6(1): 18. DOI: 10.1038/srep28741
  6. Mu H, Chai H, Lin PH, Yao Q, Chen C. Current update on HIV-associated vascular disease and endothelial dysfunction. World Journal of Surgery. 2007; 31(4): 632643. DOI: 10.1007/s00268-006-0730-0
  7. Arnaiz de las Revillas F, Gonzalez-Quintanilla V, Parra J, Palacios E, Gonzalez-Rico C, Armiñanzas C, et al. Evaluation of endothelial function and subclinical atherosclerosis in patients with HIV infection. Scientific Reports. 2021; 11(1): 112. DOI: 10.1038/s41598-021-97795-2
  8. Bonou M, Kapelios CJ, Athanasiadi E, Mavrogeni SI, Psichogiou M, Barbetseas J. Imaging modalities for cardiovascular phenotyping in asymptomatic people living with HIV. Vascular Medicine (London, England). 2021; 26(3): 326337. DOI: 10.1177/1358863X20978702
  9. Saunders W. KDOQI clinical practice guidelines and clinical practice recommendations for diabetes and chronic kidney disease. American Journal of Kidney Disease. 2007; 49(2): S1254. DOI: 10.1053/j.ajkd.2006.12.005
  10. Corretti MC, Anderson TJ, Benjamin EJ, Celermajer D, Charbonneau F, Creager MA, et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: A report of the International Brachial Artery Reactivity Task Force. Journal of the American College of Cardiology. 2002; 39(2): 257265. DOI: 10.1016/S0735-1097(01)01746-6
  11. Juonala M, Viikari JS, Laitinen T, Marniemi J, Helenius H, Rönnemaa T, et al. Interrelations between brachial endothelial function and carotid intima-media thickness in young adults: The cardiovascular risk in young Finns study. Circulation. 2004; 110(18): 29182923. DOI: 10.1161/01.CIR.0000147540.88559.00
  12. Allan PL. The carotid and vertebral arteries; transcranial colour Doppler. In: Pozniak MA, Allan PL (eds.), Clinical Doppler ultrasound e-book: Expert consult: Online and prmt. London: Churchill Livingstone; 2013. 39. Print Oct 24; 39.
  13. Nkeh-Chungag BN, Goswami N, Engwa GA, Sewani-Rusike CR, Mbombela V, Webster I, et al. Relationship between endothelial function, antiretroviral treatment and cardiovascular risk factors in HIV patients of African descent in South Africa: A cross-sectional study. Journal of Clinical Medicine. 2021; 10(3): 392. DOI: 10.3390/jcm10030392
  14. Bush KNV, Teel JL, Watts JA, Gore RS, Alvarado G, Harper NL, et al. association of endothelial dysfunction and antiretroviral therapy in early HIV Infection. JAMA Network Open. 2019; 2(10): e1913615. DOI: 10.1001/jamanetworkopen.2019.13615
  15. Torriani FJ, Komarow L, Paker RA, et al. Endothelial function in Human immunodeficiency virus-infected anti-retroviral naive subjects before and after starting potent antiretroviral therapy; The ACTG(AIDS clinical trial group) study5152S. Journal of the American College of Cardiology. 2008 Aug 12; 52(7): 56976. DOI: 10.1016/j.jacc.2008.04.049
  16. Bloomfield GS, Hogan JW, Keter A, Sang E, Carter EJ, Velazquez EJ, et al. Hypertension and obesity as cardiovascular risk factors among HIV seropositive patients in Western Kenya. PloS one. 2011; 6(7): e22288. DOI: 10.1371/journal.pone.0022288
  17. Dysangco A, Liu Z, Stein JH, Dubé MP, Gupta SK. HIV infection, antiretroviral therapy, and measures of endothelial function, inflammation, metabolism, and oxidative stress. PLoS One. 2017; 12(8): e0183511. DOI: 10.1371/journal.pone.0183511
  18. Widlansky ME, Gokce N, Keaney, JF Jr., Vita JA. The clinical implications of endothelial dysfunction. Journal of the American College of Cardiology. 2003; 42(7): 11491160. DOI: 10.1016/S0735-1097(03)00994-X
  19. Singh A, Satchell SC. Microalbuminuria: aCuses and implications. Pediatric Nephrology. 2011; 26(11): 19571965. DOI: 10.1007/s00467-011-1777-1
  20. Busch H, Heyen P, Kaufmann C, Rahn K, Zidek W. Albuminuria in HIV-infected patients. AIDS Research and Human Retroviruses. 1994; 10(6): 717720. DOI: 10.1089/aid.1994.10.717
  21. Huhn GD, Shamblaw DJ, Baril JG, Hsue PY, Mills BL, Nguyen-Cleary T, et al. Atherosclerotic cardiovascular disease risk profile of tenofovir alafenamide versus tenofovir disoproxil fumarate. Open Forum Infectious Diseases. 2020; 7(1): ofz472. DOI: 10.1093/ofid/ofz472
  22. Tongma C, Shikuma CM, Nakamoto BK, Kallianpur KJ, Umaki TM, Barbour JD, et al. Albuminuria as a marker of cardiovascular risk in HIV-infected individuals receiving stable antiretroviral therapy. Hawai’i Journal of Medicine & Public Health. 2013; 72(9 Suppl 4): 34.
  23. Fourie C, Schutte A, Smith W, Kruger A, Van Rooyen J. Endothelial activation and cardiometabolic profiles of treated and never-treated HIV infected Africans. Atherosclerosis. 2015; 240(1): 154160. DOI: 10.1016/j.atherosclerosis.2015.03.015
  24. Schoffelen AF, De Groot E, Tempelman HA, Visseren FL, Hoepelman AI, Barth RE. Carotid intima media thickness in mainly female HIV-infected subjects in rural South Africa: Association with cardiovascular but not HIV-related factors. Clinical Infectious Diseases. 2015; 61(10): 16061614. DOI: 10.1093/cid/civ586
  25. Hileman CO, Carman TL, Longenecker CT, Labbato DE, Storer NJ, White CA, et al. Rate and predictors of carotid artery intima media thickness progression in antiretroviral-naive HIV-infected and uninfected adults: A 48-week matched prospective cohort study. Antiviral Therapy. 2013; 18(7): 921929. DOI: 10.3851/IMP2651
  26. Solages A, Vita JA, Thornton DJ, Murray J, Heeren T, Craven DE, et al. Endothelial function in HIV-infected persons. Clinical Infectious Diseases. 2006; 42(9): 13251332.
  27. Lorenz M, Stephan C, Harmjanz A, Staszewski S, Buehler A, Bickel M, et al. Both long-term HIV infection and highly active antiretroviral therapy are independent risk factors for early carotid atherosclerosis. Atherosclerosis. 2008; 196(2): 720726. DOI: 10.1016/j.atherosclerosis.2006.12.022
  28. Bonnet D, Aggoun Y, Szezepanski I, Bellal N, Blanche S. Arterial stiffness and endothelial dysfunction in HIV-infected children. AIDS. 2004; 18(7): 10371041. DOI: 10.1097/00002030-200404300-00012
  29. Stein JH, Kime N, Korcarz CE, Ribaudo H, Currier JS, Delaney JC. Effects of HIV infection on arterial endothelial function: Results from a large pooled cohort analysis. Arteriosclerosis, Thrombosis, and Vascular Biology. 2021; 41(1): 512522. DOI: 10.1161/ATVBAHA.120.315435
  30. Thijssen DH, Black MA, Pyke KE, Padilla J, Atkinson G, Harris RA, et al. Assessment of flow-mediated dilation in humans: A methodological and physiological guideline. American Journal of Physiology—Heart and Circulatory Physiology. 2011; 300(1): H2H12. DOI: 10.1152/ajpheart.00471.2010
  31. Strijdom H, De Boever P, Walzl G, Essop MF, Nawrot TS, Webster I, et al. Cardiovascular risk and endothelial function in people living with HIV/AIDS: Design of the multi-site, longitudinal EndoAfrica study in the Western Cape Province of South Africa. BMC Infectious Diseases. 2017; 17(1): 19. DOI: 10.1186/s12879-016-2158-y
DOI: https://doi.org/10.5334/gh.1264 | Journal eISSN: 2211-8179
Language: English
Submitted on: Feb 6, 2023
Accepted on: Aug 22, 2023
Published on: Oct 20, 2023
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2023 Aisha M. Nalado, Bala Waziri, Anas Ismail, Nafiu Umar, Zainab U. Ibrahim, Patience Obiagwu, Baba M. Musa, Mahmoud U. Sani, Aliyu Abdu, Faisal S. Dankishiya, Mansur A. Ramalan, Hadiza Saidu, Usman J. Wudil, C. William Wester, Muktar H. Aliyu, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.